Cargando…
Primary and secondary angiosarcomas: a comparative single-center analysis
BACKGROUND: Angiosarcomas (AS) are rare vascular malignancies. They are subdivided into primary (PAS) and secondary angiosarcomas (SAS). The objective was to compare the characteristics of AS subtypes. METHODS: Eighteen PAS and ten SAS patients treated at our institution between 2004 and 2012 were i...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582641/ https://www.ncbi.nlm.nih.gov/pubmed/26413264 http://dx.doi.org/10.1186/s13569-015-0028-9 |
_version_ | 1782391736675336192 |
---|---|
author | Hillenbrand, Thorsten Menge, Franka Hohenberger, Peter Kasper, Bernd |
author_facet | Hillenbrand, Thorsten Menge, Franka Hohenberger, Peter Kasper, Bernd |
author_sort | Hillenbrand, Thorsten |
collection | PubMed |
description | BACKGROUND: Angiosarcomas (AS) are rare vascular malignancies. They are subdivided into primary (PAS) and secondary angiosarcomas (SAS). The objective was to compare the characteristics of AS subtypes. METHODS: Eighteen PAS and ten SAS patients treated at our institution between 2004 and 2012 were included in this study. RESULTS: Median age of PAS and SAS patients was 52.9 and 64.2 years, respectively (p = 0.1448). The percentage of women was 27.8% for PAS, but 80.0% for SAS (p = 0.0163). While PAS occurred throughout the body, the majority of SAS arose from the breast (p = 0.0012). All SAS were radiation-induced with a median latency of 7.7 years. The majority of patients with PAS and SAS underwent surgery as primary or recurrence treatment (p > 0.95). Local recurrence was developed by 27.8% of PAS and 50.0% of SAS (p = 0.4119). 61.1% of PAS metastasized, but only 40.0% of SAS (p = 0.4328). Median overall survival for PAS and SAS was 19 and 57 months, respectively (p = 0.2306). CONCLUSION: Radical surgery remains the mainstay of both primary and recurrence treatment. SAS show a high local recurrence rate, while PAS tend towards developing early metastases. Overall, prognosis is poor for both groups. |
format | Online Article Text |
id | pubmed-4582641 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45826412015-09-26 Primary and secondary angiosarcomas: a comparative single-center analysis Hillenbrand, Thorsten Menge, Franka Hohenberger, Peter Kasper, Bernd Clin Sarcoma Res Research BACKGROUND: Angiosarcomas (AS) are rare vascular malignancies. They are subdivided into primary (PAS) and secondary angiosarcomas (SAS). The objective was to compare the characteristics of AS subtypes. METHODS: Eighteen PAS and ten SAS patients treated at our institution between 2004 and 2012 were included in this study. RESULTS: Median age of PAS and SAS patients was 52.9 and 64.2 years, respectively (p = 0.1448). The percentage of women was 27.8% for PAS, but 80.0% for SAS (p = 0.0163). While PAS occurred throughout the body, the majority of SAS arose from the breast (p = 0.0012). All SAS were radiation-induced with a median latency of 7.7 years. The majority of patients with PAS and SAS underwent surgery as primary or recurrence treatment (p > 0.95). Local recurrence was developed by 27.8% of PAS and 50.0% of SAS (p = 0.4119). 61.1% of PAS metastasized, but only 40.0% of SAS (p = 0.4328). Median overall survival for PAS and SAS was 19 and 57 months, respectively (p = 0.2306). CONCLUSION: Radical surgery remains the mainstay of both primary and recurrence treatment. SAS show a high local recurrence rate, while PAS tend towards developing early metastases. Overall, prognosis is poor for both groups. BioMed Central 2015-05-23 /pmc/articles/PMC4582641/ /pubmed/26413264 http://dx.doi.org/10.1186/s13569-015-0028-9 Text en © Hillenbrand et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Hillenbrand, Thorsten Menge, Franka Hohenberger, Peter Kasper, Bernd Primary and secondary angiosarcomas: a comparative single-center analysis |
title |
Primary and secondary angiosarcomas: a comparative single-center analysis |
title_full |
Primary and secondary angiosarcomas: a comparative single-center analysis |
title_fullStr |
Primary and secondary angiosarcomas: a comparative single-center analysis |
title_full_unstemmed |
Primary and secondary angiosarcomas: a comparative single-center analysis |
title_short |
Primary and secondary angiosarcomas: a comparative single-center analysis |
title_sort | primary and secondary angiosarcomas: a comparative single-center analysis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582641/ https://www.ncbi.nlm.nih.gov/pubmed/26413264 http://dx.doi.org/10.1186/s13569-015-0028-9 |
work_keys_str_mv | AT hillenbrandthorsten primaryandsecondaryangiosarcomasacomparativesinglecenteranalysis AT mengefranka primaryandsecondaryangiosarcomasacomparativesinglecenteranalysis AT hohenbergerpeter primaryandsecondaryangiosarcomasacomparativesinglecenteranalysis AT kasperbernd primaryandsecondaryangiosarcomasacomparativesinglecenteranalysis |